{"id":"W1821838519","doi":"10.1111/j.1526-4637.2012.01478.x","title":"Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study","year":2012,"lang":"en","type":"article","venue":"Pain Medicine","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Grifols","keywords":"Medicine; Neuropathic pain; Visual analogue scale; Quality of life (healthcare); Refractory (planetary science); Adjuvant; McGill Pain Questionnaire; Clinical Global Impression; Clinical trial; Anesthesia; Physical therapy; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009810147,0.0003153899,0.0009890816,0.0001291419,0.00009659164,0.000005397873,0.0001729021,0.00009399599,0.0000372014],"category_scores_gemma":[0.003411813,0.0002070057,0.00003650106,0.0001369587,0.0001399758,0.0001029274,0.00006717078,0.0001274588,0.000003068928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001103718,"about_ca_system_score_gemma":0.00007721187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007770877,"about_ca_topic_score_gemma":0.00002349088,"domain_scores_codex":[0.9964123,0.001551965,0.000874915,0.0004034888,0.0003587634,0.0003985194],"domain_scores_gemma":[0.9966349,0.001794633,0.000385183,0.0006714719,0.0001693013,0.0003445174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04898521,0.04881255,0.0178333,0.0006177382,0.001388778,0.0002028642,0.02581123,0.000002339657,0.06184192,0.0001142885,0.0002667975,0.794123],"study_design_scores_gemma":[0.3547499,0.3262422,0.276139,0.003332786,0.003682462,0.00007779844,0.01305437,0.002822968,0.007534022,0.0001439101,0.01150187,0.0007187539],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893227,0.003452139,0.001109367,0.0006494971,0.0001807933,0.004977138,0.00004908808,0.00003469473,0.0002246352],"genre_scores_gemma":[0.9960126,0.0005829413,0.002081441,0.0005911111,0.0001967974,0.0001159769,0.0001609763,0.00004660211,0.000211573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7934042,"threshold_uncertainty_score":0.8441446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04808088824621691,"score_gpt":0.3479523996011704,"score_spread":0.2998715113549534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}